News
Peethaambaran Kunnathoor, Chennai Tuesday, July 1, 2025, 08:00 Hrs [IST] ...
In order to ensure smooth implementation of the recently released Guidance Document for Export No Objection Certificates (NOCs), the Drugs Controller General of India (DCGI) has responded on certain ...
Our Bureau, Mumbai Tuesday, July 1, 2025, 12:15 Hrs [IST] ...
API China 2025 concludes with strong turnout and industry-wide momentum: Our Bureau, Mumbai Tuesday, July 1, 2025, 12:30 Hrs [IST] The 92nd edition of API China successfully wrapp ...
Hansa Biopharma presents positive outcomes of 5-year follow-up study of imlifidase in kidney transplantation at ESOT Congress: Lund, Sweden Tuesday, July 1, 2025, 12:00 Hrs [IST] ...
Addex Therapeutics leads CHF 2 million investment in Stalicla to advance precision medicine in neuropsychiatric disorders: Geneva, Switzerland Tuesday, July 1, 2025, 11:00 Hrs [IS ...
WuXi Biologics introduces next-generation platform WuXiHigh2.0 for high-concentration biologics with protein concentration reaching 230 mg/mL: Shanghai Tuesday, July 1, 2025, 10:0 ...
Japanese MHLW grants orphan drug designation to Sanofi’s riliprubart for chronic inflammatory demyelinating polyneuropathy: Paris Tuesday, July 1, 2025, 09:00 Hrs [IST] The Mini ...
Explore new avenues for drug discovery, targeting novel bacterial pathways & mechanisms: Dr Atul Gogia: Nandita Vijayasimha, Bengaluru Tuesday, July 1, 2025, 08:00 Hrs [IST] The d ...
DCC asks SLAs to implement various regulatory decisions of CDSCO with priority for uniformity: Gireesh Babu, New Delhi Tuesday, July 1, 2025, 08:00 Hrs [IST] The Drugs Consultativ ...
But, time has now proven that the Revised UCPMP is still a toothless tiger. The DoP has recently reprimanded AbbVie Healthcare India, the Indian arm of global biopharma major AbbVie Inc, for alleged ...
India’s medical expertise in robotic surgeries draws patients from across the world: Nandita Vijayasimha, Bengaluru Tuesday, July 1, 2025, 08:00 Hrs [IST] India’s growing expe ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results